The impact of cannabis use on patients enrolled in opioid agonist therapy in Ontario, Canada

BACKGROUND: With the Canadian government legalizing cannabis in the year 2018, the potential harms to certain populations—including those with opioid use disorder—must be investigated. Cannabis is one of the most commonly used substances by patients who are engaged in medication-assisted treatment f...

Descripción completa

Detalles Bibliográficos
Autores principales: Franklyn, Alexandra M., Eibl, Joseph K., Gauthier, Graham J., Marsh, David C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5678697/
https://www.ncbi.nlm.nih.gov/pubmed/29117267
http://dx.doi.org/10.1371/journal.pone.0187633

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5678697/
https://www.ncbi.nlm.nih.gov/pubmed/29117267
http://dx.doi.org/10.1371/journal.pone.0187633

Ejemplares similares